Continuation of same programmed death-1 inhibitor regime beyond progression is a novel option for advanced gastric cancer.

Autor: Li, Jiasong1,2 (AUTHOR), Ding, Fang3 (AUTHOR), Zhang, Shasha1 (AUTHOR), Jia, Yuanyuan1 (AUTHOR), Zhang, Tianhang1,2 (AUTHOR), Wang, Siqi1,2 (AUTHOR), Liu, Qingyi4 (AUTHOR) liuqingyi123@aliyun.com, Guo, Zhanjun1 (AUTHOR) zjguo5886@aliyun.com
Zdroj: BMC Cancer. 10/18/2024, Vol. 24 Issue 1, p1-11. 11p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje